Clinical Trial Update: MaSS - Maastricht Sarcopenia Study

View source ↗

Summary

The Maastricht Sarcopenia Study (MaSS) sponsored by Maastricht University Medical Center has completed its clinical trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcopenia

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Sarcopenia | Status: COMPLETED